Udupi: Sri Krishna Mutt to host Zakir Hussain’s concert

Bengaluru, Apr 20: A ruckus erupted in Padarayanapura on Sunday allegedly over shifting of suspected COVID-19 persons to quarantine facility by the Bruhat Bengaluru Mahanagara Palike (BBMP) officials.

The incident occurred in the late evening at Padarayanapura which is recognized as a 'Red Zone' when BBMP officials went to bring 15 secondary contacts of corona positive patients.

However, some people and youth created ruckus and broke the barricade and removed police post which was stalled in the area.

Soon after receiving the information, Bengaluru South Deputy Commissioner of Police reached the spot and brought the situation under control.

"Lockdown continues, please remain indoors.Tomorrow will be as it was till today. We Understand your situation and appreciate your cooperation," tweeted Commissioner of Police, Bengaluru City, Bhaskar Rao.

In Karnataka, 384 people have detected positive for COVID-19, of which 14 people have succumbed to the infection, as per the Union Health Ministry.

Tirupati, Feb 12: A middle-aged man committed suicide out of fear that he was infected with the dreaded Coronavirus (COVID-19), which has killed over 1000 in China. The deceased identified as Balakrishna (50) was suffering from hypertension. He killed self, after being discharged from hospital, fearing it would spread to his family.  The incident happened in Chittoor district on Monday but came to light only on Tuesday.

Balakrishna was treated in Tirupati last week and told that he had an infection. After two days in the hospital, he got better and returned to his village in Chittoor district on Sunday. But fearing that he was infected with COVID-19, Balakrishna isolated himself from his family. Before committing suicide, he surfed many videos about Coronavirus and also behaved weirdly with the family members by warning them against coming close to him.

“He remained aloof, saying he was infected with coronavirus and asked his family not to come near him. When they tried to approach him, he got agitated, threw stones at them and then locked himself in a room," district medical and health officer Dr M Penchalaiah said.

He was found hanging from a tree near his mother’s grave on the village outskirts. The tragic incident took place in Seshama Naidu Kandriga in Thottambedu block.

According to reports, he was suffering from cold and fever. He went to Tirupati hospital where doctors gave him medicines for viral infection and advised him to wear mask.  He wrongly thought he had coronavirus. However, doctors told Balakrishna he did not have coronavirus.

His son Balamurali said that his father panicked and started saying he needed to kill himself to keep other safe from him and coronavirus. “He began to pelt stones and things at us to keep us away from him,” Balamurali said.

“My father was all worried that the virus would spread to us. He hanged himself to save us,” Murali said.

Thottambedu police sub-inspector Venkata Subbaiah said no case was registered as the family refused to lodge a complaint. Till now, no Coronavirus case has been reported in Andhra Pradesh and Telangana.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.